Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Kenya
35%
Low-middle Income Countries
34%
Supportive Care
32%
Acute Myeloid Leukemia
31%
Netherlands
28%
Clinical Value
28%
Pediatric Patients
28%
CD33
28%
Childhood Cancer Care
28%
De Novo Acute Myeloid Leukemia
28%
Pediatric Cancer Patients
28%
Prospective Cohort Study
28%
Gemtuzumab Ozogamicin
28%
Patient-centered
28%
Parents/guardians
21%
Legal Guardian
21%
Pediatric Leukemia
14%
Pathogen Infection
14%
Children with Cancer
14%
Curative Intent
14%
Infection Prevention
14%
Monitoring Capability
14%
Clinical Outcomes
14%
Newly Diagnosed
12%
Childhood Cancer
11%
Survival Rate
11%
High-income Countries
8%
Bone Marrow Aspiration
8%
Leukemia Patients
7%
Pathogen Colonization
7%
Fever Episode
7%
Peer-reviewed Publications
7%
Malnutrition Prevalence
7%
Pathogen Exposure
7%
Rectal Colonization
7%
Supportive Care Intervention
7%
Academic Engagement
7%
Childrens
7%
Politicians
7%
Nutritional Care
7%
Nutritional Assessment
7%
Ethics Committees
7%
Informed Consent
7%
Neutropenic Fever
7%
Fungal Pathogens
7%
Referral Hospital
7%
Ethics
7%
Institutional Research
7%
Care Prevention
7%
Oncology Ward
7%
Medicine and Dentistry
Childhood Cancer
100%
Acute Myeloid Leukemia
76%
Low and Middle Income Countries
65%
Pediatric Acute Myeloid Leukemia
61%
Supportive Care
61%
Malignant Neoplasm
39%
Survival Rate
38%
Treatment Outcome
28%
Prospective Cohort Study
28%
Infection
22%
Patient Referral
20%
Overall Survival
15%
Cytarabine
14%
Treatment Response
14%
Malnutrition
11%
Pathogen
11%
Prevalence
11%
Infection Prevention
11%
Febrile Neutropenia
9%
Event Free Survival
9%
Etoposide
9%
Bone Marrow Biopsy
8%
Nutrition Assessment
5%
Informed Consent
5%
Nutritional Support
5%
Logistic Regression Analysis
5%
Chi Square Test
5%
Pharmacology, Toxicology and Pharmaceutical Science
Teicoplanin
28%
Pharmacokinetics
28%
De Novo Acute Myeloid Leukemia
28%
6 Hydroxymelatonin O Sulfate
28%
Gemtuzumab Ozogamicin
28%
Creatinine
14%
Cross-Sectional Study
14%
Acute Myeloid Leukemia
12%
Childhood Cancer
10%
Diseases
8%
Chemotherapy Regimens
7%
Recurrence Free Survival
5%
Clinical Trial
5%